Kaleido Biosciences (KLDO) Competitors $0.0001 0.00 (0.00%) As of 08/29/2025 01:46 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock KLDO vs. OMQS, SBIG, AGMH, LFLY, SVRE, ZPTA, MVLA, PRST, ELYS, and GROMShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include OMNIQ (OMQS), SpringBig (SBIG), AGM Group (AGMH), Leafly (LFLY), SaverOne 2014 (SVRE), Zapata Computing (ZPTA), Movella (MVLA), Presto Automation (PRST), Elys BMG Group (ELYS), and Grom Social Enterprises (GROM). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. Its Competitors OMNIQ SpringBig AGM Group Leafly SaverOne 2014 Zapata Computing Movella Presto Automation Elys BMG Group Grom Social Enterprises Kaleido Biosciences (NASDAQ:KLDO) and OMNIQ (NASDAQ:OMQS) are both small-cap computer software companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Which has higher valuation and earnings, KLDO or OMQS? OMNIQ has higher revenue and earnings than Kaleido Biosciences. OMNIQ is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKaleido Biosciences$1.10M0.00-$95.48M-$2.240.00OMNIQ$81.19M0.02-$29.43M-$0.47-0.24 Does the media refer more to KLDO or OMQS? In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled OMNIQ'saverage media sentiment score. Company Overall Sentiment Kaleido Biosciences Neutral OMNIQ Neutral Is KLDO or OMQS more profitable? Kaleido Biosciences has a net margin of 0.00% compared to OMNIQ's net margin of -34.33%. Company Net Margins Return on Equity Return on Assets Kaleido BiosciencesN/A N/A N/A OMNIQ -34.33%N/A -61.97% Do institutionals & insiders have more ownership in KLDO or OMQS? 81.6% of Kaleido Biosciences shares are owned by institutional investors. Comparatively, 5.7% of OMNIQ shares are owned by institutional investors. 9.0% of Kaleido Biosciences shares are owned by insiders. Comparatively, 11.6% of OMNIQ shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, KLDO or OMQS? Kaleido Biosciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, OMNIQ has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. SummaryOMNIQ beats Kaleido Biosciences on 6 of the 10 factors compared between the two stocks. Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$4K$155.80M$5.66B$9.84BDividend YieldN/A3.78%3.93%4.04%P/E Ratio0.0041.2983.2726.61Price / Sales0.005,361.87451.26176.46Price / CashN/A13.1937.7059.65Price / BookN/A71.5210.556.59Net Income-$95.48M-$90.99M$3.27B$266.12M7 Day PerformanceN/A9.89%0.47%0.17%1 Month PerformanceN/A13.15%5.93%3.03%1 Year PerformanceN/A414.88%48.79%19.98% Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/A$0.00flatN/AN/A$4K$1.10M0.0080OMQSOMNIQN/A$0.12-7.1%N/A-45.2%$1.54M$81.19M-0.05190Gap DownSBIGSpringBigN/A$0.03-11.0%N/AN/A$1.41M$28.37M-0.38160AGMHAGM Group1.3929 of 5 stars$2.60+17.1%N/A-96.4%$1.17M$32.04M0.0020High Trading VolumeLFLYLeafly1.3161 of 5 stars$0.25+8.6%$9.18+3,576.4%-89.2%$783K$35.87M-0.11260News CoverageGap UpSVRESaverOne 20140.4445 of 5 stars$1.97+3.1%N/A-98.8%$390K$460K0.0040News CoverageAnalyst UpgradeZPTAZapata Computing0.316 of 5 stars$0.01+4,900.0%N/A-98.0%$386K$5.68M0.0050MVLAMovellaN/A$0.00flatN/A-92.6%$25K-$559K0.003PRSTPresto AutomationN/A$0.00+100.0%N/A-97.9%$20K$19.05M0.004Gap UpELYSElys BMG GroupN/A$0.00flatN/AN/A$8K$43.86M0.0090GROMGrom Social Enterprises0.1509 of 5 stars$0.00flatN/A-98.9%$5K$3.72M0.00450 Related Companies and Tools Related Companies OMNIQ Competitors SpringBig Competitors AGM Group Competitors Leafly Competitors SaverOne 2014 Competitors Zapata Computing Competitors Movella Competitors Presto Automation Competitors Elys BMG Group Competitors Grom Social Enterprises Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLDO) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLDO Stock Alerts